982186023	982186023	CD	B-NP	O
|	|	NNP	I-NP	O
GEMC	GEMC	NNP	I-NP	O
|	|	VBD	B-VP	O
68534684	68534684	CD	B-NP	O
|	|	NN	I-NP	O
|	|	NN	I-NP	O
1149989	1149989	CD	B-NP	O
|	|	CC	I-NP	O
4/6/2006	4/6/2006	CD	I-NP	O
12	12	CD	I-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
AM	AM	VBP	B-VP	O
|	|	JJ	B-NP	B-protein
C-DIFF	C-DIFF	NN	I-NP	I-protein
.	.	.	O	O

COLITIS	COLITIS	NN	B-NP	O
|	|	VBZ	B-VP	O
Unsigned	Unsigned	NNP	B-NP	O
|	|	NNP	I-NP	O
DIS	DIS	NNP	I-NP	O
|	|	NNP	I-NP	O
Admission	Admission	NNP	I-NP	O
Date	Date	NNP	I-NP	O
:	:	:	O	O
5/15/2006	5/15/2006	CD	B-NP	O
Report	Report	NNP	I-NP	O
Status	Status	NNP	I-NP	O
:	:	:	O	O
Unsigned	Unsigned	NNP	B-NP	O
Discharge	Discharge	NNP	I-NP	O
Date	Date	NNP	I-NP	O
:	:	:	O	O
7/30/2006	7/30/2006	CD	B-NP	O
ATTENDING	ATTENDING	NN	I-NP	O
:	:	:	O	O
TRENTHAM	TRENTHAM	NN	B-NP	O
,	,	,	O	O
DEL	DEL	NNP	B-NP	O
GUADALUPE	GUADALUPE	NNP	I-NP	O
MD	MD	NNP	I-NP	O
HISTORY	HISTORY	NNP	I-NP	O
OF	OF	IN	B-PP	O
PRESENT	PRESENT	NNP	B-NP	O
ILLNESS	ILLNESS	NNP	I-NP	O
:	:	:	O	O
Mr.	Mr.	NNP	B-NP	O
Klaja	Klaja	NNP	I-NP	O
is	be	VBZ	B-VP	O
an	an	DT	B-NP	O
81-year-old	81-year-old	JJ	I-NP	O
gentleman	gentleman	NN	I-NP	O
whose	whose	WP$	B-NP	O
chief	chief	JJ	I-NP	O
complaint	complaint	NN	I-NP	O
was	be	VBD	B-VP	O
abdominal	abdominal	JJ	B-NP	O
pain	pain	NN	I-NP	O
and	and	CC	I-NP	O
diarrhea	diarrhea	NN	I-NP	O
.	.	.	O	O

He	He	PRP	B-NP	O
had	have	VBD	B-VP	O
a	a	DT	B-NP	O
past	past	JJ	I-NP	O
medical	medical	JJ	I-NP	O
history	history	NN	I-NP	O
of	of	IN	B-PP	O
ischemic	ischemic	JJ	B-NP	O
cardiomyopathy	cardiomyopathy	NN	I-NP	O
and	and	CC	I-NP	O
recent	recent	JJ	I-NP	O
complex	complex	NN	I-NP	O
medical	medical	JJ	I-NP	O
history	history	NN	I-NP	O
including	include	VBG	B-PP	O
a	a	DT	B-NP	O
septic	septic	JJ	I-NP	O
right	right	JJ	I-NP	O
knee	knee	NN	I-NP	O
arthritis	arthritis	NN	I-NP	O
with	with	IN	B-PP	O
MRSA	MRSA	NN	B-NP	O
complicated	complicate	VBN	B-VP	O
by	by	IN	B-PP	O
a	a	DT	B-NP	O
PICC	PICC	NN	I-NP	O
line-induced	line-induced	JJ	I-NP	O
right	right	JJ	I-NP	O
upper	upper	JJ	I-NP	O
extremity	extremity	NN	I-NP	O
DVT	DVT	NN	I-NP	O
followed	follow	VBN	B-VP	O
by	by	IN	B-PP	O
bacteremia	bacteremia	NN	B-NP	O
with	with	IN	B-PP	O
multi-resistant	multi-resistant	JJ	B-NP	O
Klebsiella	Klebsiella	NNP	I-NP	O
pneumoniae	pneumoniae	NNS	I-NP	O
,	,	,	O	O
treated	treat	VBN	B-VP	O
with	with	IN	B-PP	O
meropenem	meropenem	NN	B-NP	O
for	for	IN	B-PP	O
14	14	CD	B-NP	O
days	day	NNS	I-NP	O
with	with	IN	B-PP	O
the	the	DT	B-NP	O
course	course	NN	I-NP	O
ending	end	VBG	B-VP	O
on	on	IN	B-PP	O
11/11/2006	11/11/2006	CD	B-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
presented	present	VBD	B-VP	O
with	with	IN	B-PP	O
left	left	JJ	B-NP	B-protein
lower	low	JJR	I-NP	I-protein
quadrant	quadrant	JJ	I-NP	I-protein
abdominal	abdominal	JJ	I-NP	I-protein
pain	pain	NN	I-NP	I-protein
during	during	IN	B-PP	O
his	his	PRP$	B-NP	O
last	last	JJ	I-NP	B-protein
admission	admission	NN	I-NP	I-protein
2	2	CD	B-NP	I-protein
weeks	week	NNS	I-NP	I-protein
ago	ago	RB	B-VP	O
associated	associate	VBN	I-VP	O
with	with	IN	B-PP	O
low-volume	low-volume	JJ	B-NP	O
mucus	mucus	NN	I-NP	O
diarrhea	diarrhea	NN	I-NP	O
,	,	,	O	O
C.	C.	FW	B-NP	O
diff	diff	FW	I-NP	O
toxin	toxin	NN	I-NP	O
assay	assay	NN	I-NP	O
was	be	VBD	B-VP	O
at	at	IN	B-PP	O
that	that	DT	B-NP	O
time	time	NN	I-NP	O
negative	negative	JJ	B-ADJP	O
on	on	IN	B-PP	O
1/24	1/24	CD	B-NP	O
Abdominal	Abdominal	JJ	I-NP	O
CT	CT	NN	I-NP	O
showed	show	VBD	B-VP	O
diverticulosis	diverticulosis	NN	B-NP	O
with	with	IN	B-PP	O
stranding	stranding	NN	B-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
sigmoid	sigmoid	JJ	I-NP	O
colon	colon	NN	I-NP	O
.	.	.	O	O

Blood	Blood	NN	B-NP	B-cell_line
cultures	culture	NNS	I-NP	I-cell_line
grew	grow	VBD	B-VP	O
klebsiella	klebsiella	NN	B-NP	O
,	,	,	O	O
treated	treat	VBN	B-VP	O
with	with	IN	B-PP	O
14	14	CD	B-NP	O
days	day	NNS	I-NP	O
of	of	IN	B-PP	O
meropenem	meropenem	NN	B-NP	O
as	as	IN	B-SBAR	O
previously	previously	RB	B-ADVP	O
noted	note	VBN	B-VP	O
.	.	.	O	O

However	However	RB	B-ADVP	O
,	,	,	O	O
since	since	IN	B-SBAR	O
this	this	DT	B-NP	O
discharge	discharge	NN	I-NP	O
,	,	,	O	O
the	the	DT	B-NP	O
mild	mild	JJ	I-NP	O
abdominal	abdominal	JJ	I-NP	O
pain	pain	NN	I-NP	O
persisted	persist	VBD	B-VP	O
.	.	.	O	O

He	He	PRP	B-NP	O
continues	continue	VBZ	B-VP	O
to	to	TO	I-VP	O
have	have	VB	I-VP	O
low-grade	low-grade	JJ	B-NP	O
mucus	mucus	NN	I-NP	O
diarrhea	diarrhea	NN	I-NP	O
about	about	IN	B-PP	O
5	5	CD	B-NP	O
times	time	NNS	I-NP	O
a	a	DT	B-NP	O
day	day	NN	I-NP	O
,	,	,	B-NP	O
not	not	RB	I-NP	O
associated	associate	VBN	B-VP	O
with	with	IN	B-PP	O
fever	fever	NN	B-NP	O
,	,	,	O	O
chills	chill	NNS	B-NP	O
or	or	CC	O	O
anorexia	anorexia	NN	B-NP	O
.	.	.	O	O

Over	Over	IN	B-PP	O
the	the	DT	B-NP	O
last	last	JJ	I-NP	O
2	2	CD	I-NP	O
days	day	NNS	I-NP	O
prior	prior	RB	B-ADVP	O
to	to	TO	B-PP	O
this	this	DT	B-NP	O
admission	admission	NN	I-NP	O
,	,	,	O	O
the	the	DT	B-NP	O
diarrhea	diarrhea	NN	I-NP	O
became	become	VBD	B-VP	O
high	high	JJ	B-ADJP	O
volume	volume	NN	I-ADJP	O
,	,	,	O	O
still	still	RB	B-ADVP	O
nonbloody	nonbloody	JJ	B-ADJP	O
and	and	CC	O	O
not	not	RB	B-VP	O
associated	associate	VBN	I-VP	O
again	again	RB	B-ADVP	O
with	with	IN	B-PP	O
fever	fever	NN	B-NP	O
or	or	CC	I-NP	O
chills	chill	NNS	I-NP	O
.	.	.	O	O

He	He	PRP	B-NP	O
was	be	VBD	B-VP	O
brought	bring	VBN	I-VP	O
into	into	IN	B-PP	O
the	the	DT	B-NP	O
emergency	emergency	NN	I-NP	O
department	department	NN	I-NP	O
at	at	IN	B-PP	O
which	which	WDT	B-NP	O
time	time	NN	B-NP	O
,	,	,	O	O
he	he	PRP	B-NP	O
was	be	VBD	B-VP	O
afebrile	afebrile	JJ	B-ADJP	O
with	with	IN	B-PP	O
a	a	DT	B-NP	O
blood	blood	NN	I-NP	O
pressure	pressure	NN	I-NP	O
of	of	IN	B-PP	O
85/49	85/49	CD	B-NP	O
,	,	,	O	O
heart	heart	NN	B-NP	O
rate	rate	NN	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
80s	80	NNS	I-NP	O
,	,	,	O	O
respiratory	respiratory	JJ	B-NP	O
rate	rate	NN	I-NP	O
of	of	IN	B-PP	O
20	20	CD	B-NP	O
,	,	,	O	O
O2	O2	NN	B-NP	O
saturation	saturation	NN	I-NP	O
93	93	CD	B-NP	O
%	%	NN	I-NP	O
on	on	IN	B-PP	O
room	room	NN	B-NP	O
air	air	NN	I-NP	O
.	.	.	O	O

At	At	IN	B-PP	O
that	that	DT	B-NP	O
time	time	NN	I-NP	O
,	,	,	O	O
he	he	PRP	B-NP	O
received	receive	VBD	B-VP	O
volume	volume	NN	B-NP	O
resuscitation	resuscitation	NN	I-NP	O
with	with	IN	B-PP	O
2	2	CD	B-NP	O
liters	liter	NNS	I-NP	O
of	of	IN	B-PP	O
IV	IV	CD	B-NP	O
fluids	fluid	NNS	I-NP	O
,	,	,	O	O
stool	stool	NN	B-NP	O
samples	sample	NNS	I-NP	O
for	for	IN	B-PP	O
C.	C.	NNP	B-NP	O
diff	diff	NNP	I-NP	O
assay	assay	NN	I-NP	O
were	be	VBD	B-VP	O
sent	send	VBN	I-VP	O
.	.	.	O	O

He	He	PRP	B-NP	O
received	receive	VBD	B-VP	O
empiric	empiric	JJ	B-NP	O
therapy	therapy	NN	I-NP	O
with	with	IN	B-PP	O
p.o.	p.o.	FW	B-NP	O
vancomycin	vancomycin	NN	I-NP	O
.	.	.	O	O

An	An	DT	B-NP	O
abdominal	abdominal	JJ	I-NP	O
CT	CT	NN	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
emergency	emergency	NN	I-NP	O
department	department	NN	I-NP	O
showed	show	VBD	B-VP	O
thickening	thickening	NN	B-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
sigmoid	sigmoid	JJ	I-NP	O
colon	colon	NN	I-NP	O
and	and	CC	I-NP	O
rectum	rectum	NN	I-NP	O
.	.	.	O	O

PAST	PAST	NNP	B-NP	O
MEDICAL	MEDICAL	NNP	I-NP	O
HISTORY	HISTORY	NNP	I-NP	O
:	:	:	O	O
Includes	Include	VBZ	B-VP	O
coronary	coronary	JJ	B-NP	O
artery	artery	NN	I-NP	O
disease	disease	NN	I-NP	O
as	as	IN	B-SBAR	O
noted	note	VBN	B-VP	O
with	with	IN	B-PP	O
an	an	DT	B-NP	O
anterior	anterior	JJ	I-NP	O
MI	MI	NN	I-NP	O
in	in	IN	B-PP	O
2003	2003	CD	B-NP	O
,	,	,	O	O
that	that	WDT	B-NP	O
had	have	VBD	B-VP	O
complicated	complicate	VBN	I-VP	O
to	to	TO	B-PP	O
VT	VT	NN	B-NP	O
arrest	arrest	NN	I-NP	O
,	,	,	O	O
status	status	NN	B-NP	O
post	post	NN	I-NP	O
CABG	CABG	NN	I-NP	O
in	in	IN	B-PP	O
2003	2003	CD	B-NP	O
that	that	WDT	B-NP	O
was	be	VBD	B-VP	O
a	a	DT	B-NP	O
left	left	JJ	I-NP	O
internal	internal	JJ	I-NP	O
mammary	mammary	JJ	I-NP	O
artery	artery	NN	I-NP	O
to	to	TO	B-PP	O
LAD	LAD	NN	B-NP	O
with	with	IN	B-PP	O
saphenous	saphenous	JJ	B-NP	O
vein	vein	NN	I-NP	O
graft	graft	NN	I-NP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
PTA	PTA	NN	I-NP	B-protein
and	and	CC	I-NP	O
obtuse	obtuse	NN	I-NP	O
marginal	marginal	JJ	B-ADJP	O
.	.	.	O	O

He	He	PRP	B-NP	O
has	have	VBZ	B-VP	O
had	have	VBN	I-VP	O
a	a	DT	B-NP	O
catheterization	catheterization	NN	I-NP	O
in	in	IN	B-PP	O
3/12	3/12	CD	B-NP	O
that	that	WDT	B-NP	O
showed	show	VBD	B-VP	O
patent	patent	NN	B-NP	O
grafts	graft	NNS	I-NP	O
and	and	CC	O	O
drug-eluting	drug-eluting	JJ	B-NP	O
stent	stent	NN	I-NP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
left	left	JJ	I-NP	O
circumflex	circumflex	NN	I-NP	O
.	.	.	O	O

He	He	PRP	B-NP	O
has	have	VBZ	B-VP	O
chronic	chronic	JJ	B-NP	O
kidney	kidney	NN	I-NP	O
disease	disease	NN	I-NP	O
,	,	,	O	O
baseline	baseline	NN	B-NP	O
creatinine	creatinine	NN	I-NP	O
between	between	IN	B-PP	O
1.3	1.3	CD	B-NP	O
and	and	CC	I-NP	O
1.5	1.5	CD	I-NP	O
,	,	,	O	O
hypertension	hypertension	NN	B-NP	O
,	,	,	O	O
hypercholesterolemia	hypercholesterolemia	NN	B-NP	O
,	,	,	O	O
C.	C.	FW	B-NP	O
diff	diff	FW	I-NP	O
colitis	colitis	NN	I-NP	O
in	in	IN	B-PP	O
2003	2003	CD	B-NP	O
,	,	,	O	O
BPH	BPH	NN	B-NP	O
,	,	,	O	O
asthma	asthma	NN	B-NP	O
,	,	,	O	O
GERD	GERD	NN	B-NP	O
,	,	,	O	O
status	status	NN	B-NP	O
post	post	VBD	B-VP	O
right	right	JJ	B-NP	O
upper	upper	JJ	I-NP	O
extremity	extremity	NN	I-NP	O
PICC-related	PICC-related	JJ	I-NP	O
DVT	DVT	NN	I-NP	O
and	and	CC	I-NP	O
right	right	JJ	I-NP	O
knee	knee	NN	I-NP	O
septic	septic	JJ	I-NP	O
arthritis	arthritis	NN	I-NP	O
.	.	.	O	O

MEDICATIONS	MEDICATIONS	NNS	B-NP	O
:	:	:	O	O
aspirin	aspirin	NN	B-NP	O
81	81	CD	I-NP	O
mg	mg	NN	I-NP	O
,	,	,	O	O
Plavix	Plavix	NN	B-NP	O
75	75	CD	I-NP	O
mg	mg	NN	I-NP	O
,	,	,	O	O
Coumadin	Coumadin	NN	B-NP	O
5	5	CD	I-NP	O
mg	mg	NN	I-NP	O
,	,	,	O	O
digoxin	digoxin	NN	B-NP	O
0.125	0.125	CD	I-NP	O
mg	mg	NN	I-NP	O
,	,	,	O	O
Lasix	Lasix	NN	B-NP	O
49	49	CD	I-NP	O
mg	mg	NN	I-NP	O
daily	daily	JJ	B-ADJP	O
,	,	,	O	O
lisinopril	lisinopril	NN	B-NP	O
10	10	CD	I-NP	O
mg	mg	NN	I-NP	O
daily	daily	RB	B-ADVP	O
,	,	,	O	O
Lopressor	Lopressor	NNP	B-NP	O
25	25	CD	I-NP	O
mg	mg	NN	I-NP	O
b.i.d.	b.i.d.	RB	B-ADVP	O
,	,	,	O	O
Zocor	Zocor	NNP	B-NP	O
80	80	CD	I-NP	O
mg	mg	NN	I-NP	O
daily	daily	RB	B-ADVP	O
,	,	,	O	O
Flomax	Flomax	NN	B-NP	O
0.4	0.4	CD	I-NP	O
mg	mg	NN	I-NP	O
daily	daily	JJ	I-NP	O
and	and	CC	I-NP	O
Flovent	Flovent	JJ	I-NP	O
110	110	CD	I-NP	O
mcg	mcg	NN	I-NP	O
b.i.d.	b.i.d.	NN	I-NP	O
ALLERGIES	ALLERGIES	NN	I-NP	O
:	:	:	O	O
penicillin	penicillin	NN	B-NP	O
which	which	WDT	B-NP	O
caused	cause	VBD	B-VP	O
hives	hive	NNS	B-NP	O
and	and	CC	I-NP	O
swelling	swelling	NN	I-NP	O
.	.	.	O	O

SOCIAL	SOCIAL	JJ	B-NP	O
HISTORY	HISTORY	NN	I-NP	O
:	:	:	O	O
He	He	PRP	B-NP	O
previously	previously	RB	B-ADVP	O
a	a	DT	B-NP	O
smoker	smoker	NN	I-NP	O
.	.	.	O	O

He	He	PRP	B-NP	O
does	do	VBZ	B-VP	O
not	not	RB	I-VP	O
drink	drink	VB	I-VP	O
.	.	.	O	O

He	He	PRP	B-NP	B-DNA
is	be	VBZ	B-VP	O
a	a	DT	B-NP	O
nursing	nursing	NN	I-NP	O
home	home	NN	I-NP	O
resident	resident	NN	I-NP	O
.	.	.	O	O

FAMILY	FAMILY	NN	B-NP	O
HISTORY	HISTORY	NN	I-NP	O
:	:	:	O	O
Significant	Significant	JJ	B-ADJP	O
for	for	IN	B-PP	O
coronary	coronary	JJ	B-NP	O
artery	artery	NN	I-NP	O
disease	disease	NN	I-NP	O
,	,	,	O	O
two	two	CD	B-NP	O
brothers	brother	NNS	I-NP	O
who	who	WP	B-NP	O
had	have	VBD	B-VP	O
coronary	coronary	JJ	B-NP	O
artery	artery	NN	I-NP	O
disease	disease	NN	I-NP	O
in	in	IN	B-PP	O
their	their	PRP$	B-NP	O
60s	60	NNS	I-NP	O
.	.	.	O	O

No	No	DT	B-NP	O
family	family	NN	I-NP	O
history	history	NN	I-NP	O
of	of	IN	B-PP	O
cancer	cancer	NN	B-NP	O
.	.	.	O	O

PHYSICAL	PHYSICAL	JJ	B-NP	O
EXAMINATION	EXAMINATION	NN	I-NP	O
:	:	:	O	O
Vitals	Vital	NNS	B-NP	O
as	as	IN	B-PP	O
previous	previous	JJ	B-NP	O
noted	note	VBN	I-NP	O
,	,	,	I-NP	O
blood	blood	NN	I-NP	O
pressure	pressure	NN	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
80s/49	80s/49	CD	I-NP	O
,	,	,	O	O
heart	heart	NN	B-NP	O
rate	rate	NN	I-NP	O
80	80	CD	I-NP	O
,	,	,	O	O
regular	regular	JJ	B-NP	O
,	,	,	I-NP	O
respiratory	respiratory	JJ	I-NP	O
rate	rate	NN	I-NP	O
20	20	CD	I-NP	O
,	,	,	O	O
O2	O2	NN	B-NP	O
saturation	saturation	NN	I-NP	O
93	93	CD	B-NP	O
%	%	NN	I-NP	O
on	on	IN	B-PP	O
room	room	NN	B-NP	O
air	air	NN	I-NP	O
.	.	.	O	O

Patient	Patient	NN	B-NP	O
was	be	VBD	B-VP	O
afebrile	afebrile	JJ	B-ADJP	O
.	.	.	O	O

Pertinent	Pertinent	JJ	B-NP	O
physical	physical	JJ	I-NP	O
findings	finding	NNS	I-NP	O
included	include	VBD	B-VP	O
:	:	:	O	O
Pulmonary	Pulmonary	JJ	B-ADJP	O
:	:	:	O	O
He	He	PRP	B-NP	O
had	have	VBD	B-VP	O
a	a	DT	B-NP	O
prolonged	prolonged	JJ	I-NP	O
expiratory	expiratory	JJ	I-NP	O
phase	phase	NN	I-NP	O
,	,	,	O	O
but	but	CC	O	O
no	no	DT	B-NP	O
crackles	crackle	NNS	I-NP	O
.	.	.	O	O

Cardiovascular	Cardiovascular	JJ	B-ADJP	O
:	:	:	O	O
Distant	Distant	JJ	B-NP	O
heart	heart	NN	I-NP	O
sounds	sound	NNS	I-NP	O
,	,	,	O	O
regular	regular	JJ	B-NP	O
rate	rate	NN	I-NP	O
and	and	CC	I-NP	O
rhythm	rhythm	NN	I-NP	O
.	.	.	O	O

Normal	Normal	JJ	B-NP	O
S1	S1	NN	I-NP	B-protein
and	and	CC	I-NP	O
S2	S2	NN	I-NP	B-protein
.	.	.	O	O

No	No	DT	B-NP	O
rubs	rub	NNS	I-NP	O
or	or	CC	I-NP	O
gallops	gallop	NNS	I-NP	O
.	.	.	O	O

Systolic	Systolic	JJ	B-NP	O
ejection	ejection	NN	I-NP	O
or	or	CC	O	O
murmur	murmur	NN	B-NP	O
3/6	3/6	CD	I-NP	O
at	at	IN	B-PP	O
the	the	DT	B-NP	O
left	left	JJ	I-NP	O
lower	low	JJR	I-NP	O
sternal	sternal	JJ	I-NP	O
border	border	NN	I-NP	O
.	.	.	O	O

Abdomen	Abdoman	NNS	B-NP	O
:	:	:	O	O
Obese	Obese	JJ	B-NP	O
,	,	,	I-NP	O
distended	distended	JJ	I-NP	O
abdomen	abdomen	NN	I-NP	O
,	,	,	O	O
left	leave	VBD	B-VP	O
lower	low	JJR	B-NP	O
quadrant	quadrant	JJ	I-NP	O
tenderness	tenderness	NN	I-NP	O
to	to	TO	B-PP	O
palpation	palpation	NN	B-NP	O
.	.	.	O	O

No	No	DT	B-NP	O
rebound	rebound	NN	I-NP	O
at	at	IN	B-PP	O
this	this	DT	B-NP	O
time	time	NN	I-NP	O
.	.	.	O	O

Extremities	Extremity	NNS	B-NP	O
are	be	VBP	B-VP	O
warm	warm	JJ	B-ADJP	O
,	,	,	O	O
2	2	CD	B-NP	O
+	+	SYM	I-NP	O
pulses	pulse	NNS	I-NP	O
with	with	IN	B-PP	O
1	1	CD	B-NP	O
+	+	SYM	I-NP	O
bilateral	bilateral	JJ	I-NP	O
lower	low	JJR	I-NP	O
extremity	extremity	NN	I-NP	O
edema	edema	NN	I-NP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
shins	shin	NNS	I-NP	O
.	.	.	O	O

Neurologic	Neurologic	JJ	B-ADJP	O
:	:	:	O	O
Alert	Alert	NNP	B-NP	O
and	and	CC	O	O
oriented	orient	VBN	B-VP	O
x3	x3	NN	B-NP	O
,	,	,	O	O
cranial	cranial	JJ	B-NP	O
nerves	nerve	NNS	I-NP	O
grossly	grossly	RB	B-ADJP	O
intact	intact	JJ	I-ADJP	O
,	,	,	O	O
no	no	DT	B-NP	O
abnormalities	abnormality	NNS	I-NP	O
.	.	.	O	O

admission	admission	NN	B-NP	O
abdominal	abdominal	JJ	I-NP	O
CT	CT	NN	I-NP	O
showed	show	VBD	B-VP	O
bowel	bowel	NN	B-NP	O
wall	wall	NN	I-NP	O
thickening	thicken	VBG	B-VP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
descending	descend	VBG	I-NP	O
sigmoid	sigmoid	JJ	I-NP	O
colon	colon	NN	I-NP	O
and	and	CC	I-NP	O
rectum	rectum	NN	I-NP	O
.	.	.	O	O

Chest	Ch	JJS	B-NP	O
x-ray	x-ray	NN	I-NP	B-DNA
showed	show	VBD	B-VP	O
left-sided	left-sided	JJ	B-NP	O
pleural	pleural	JJ	I-NP	O
effusion	effusion	NN	I-NP	O
,	,	,	O	O
atelectasis	atelectasis	NN	B-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
left	left	JJ	I-NP	O
lower	low	JJR	I-NP	O
lobe	lobe	NN	I-NP	O
.	.	.	O	O

LABORATORY	LABORATORY	NN	B-NP	O
DATA	DATA	NN	I-NP	O
:	:	:	O	O
Labs	Lab	NNS	B-NP	B-protein
were	be	VBD	B-VP	O
significant	significant	JJ	B-ADJP	O
for	for	IN	B-PP	O
a	a	DT	B-NP	O
white	white	JJ	I-NP	O
count	count	NN	I-NP	O
of	of	IN	B-PP	O
15.7	15.7	CD	B-NP	O
,	,	,	O	O
hematocrit	hematocrit	NN	B-NP	O
of	of	IN	B-PP	O
35.5	35.5	CD	B-NP	O
and	and	CC	O	O
INR	INR	NN	B-NP	O
of	of	IN	B-PP	O
3.2	3.2	CD	B-NP	O
.	.	.	O	O

Electrolytes	Electrolyte	NNS	B-NP	O
were	be	VBD	B-VP	O
normal	normal	JJ	B-ADJP	O
.	.	.	O	O

Patient	Patient	NN	B-NP	O
was	be	VBD	B-VP	O
initially	initially	RB	I-VP	O
admitted	admit	VBN	I-VP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
MICU	MICU	NN	I-NP	B-DNA
for	for	IN	B-PP	O
hypertension	hypertension	NN	B-NP	O
and	and	CC	O	O
infectious	infectious	JJ	B-NP	O
etiology	etiology	NN	I-NP	O
.	.	.	O	O

He	He	PRP	B-NP	O
was	be	VBD	B-VP	O
stabilized	stabilize	VBN	I-VP	O
there	there	RB	B-ADVP	O
and	and	CC	O	O
transferred	transfer	VBN	B-VP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
floor	floor	NN	I-NP	O
within	within	IN	B-PP	O
a	a	DT	B-NP	O
few	few	JJ	I-NP	O
days	day	NNS	I-NP	O
.	.	.	O	O

HOSPITAL	HOSPITAL	NNP	B-NP	O
COURSE	COURSE	NNP	I-NP	O
:	:	:	O	O
1	1	CD	B-NP	O
.	.	.	O	O

Colitis	Colitis	NN	B-NP	O
,	,	,	O	O
presumed	presume	VBN	B-VP	O
infectious	infectious	JJ	B-NP	O
etiology	etiology	NN	I-NP	O
,	,	,	O	O
descending	descend	VBG	B-VP	O
and	and	CC	O	O
sigmoid	sigmoid	JJ	B-NP	O
colon	colon	NN	I-NP	O
.	.	.	O	O

Colitis	Colitis	NN	B-NP	O
was	be	VBD	B-VP	O
worse	worse	JJR	B-ADJP	O
over	over	IN	B-PP	O
the	the	DT	B-NP	O
last	last	JJ	I-NP	O
month	month	NN	I-NP	O
,	,	,	O	O
associated	associate	VBN	B-VP	O
with	with	IN	B-PP	O
diarrhea	diarrhea	NN	B-NP	O
.	.	.	O	O

Abdominal	Abdominal	JJ	B-NP	O
CT	CT	NN	I-NP	O
is	be	VBZ	B-VP	O
consistent	consistent	JJ	B-ADJP	O
with	with	IN	B-PP	O
an	an	DT	B-NP	O
infectious	infectious	JJ	I-NP	O
inflammatory	inflammatory	JJ	I-NP	O
bowel	bowel	NN	I-NP	O
process	process	NN	I-NP	O
.	.	.	O	O

Given	Give	VBN	B-NP	O
history	history	NN	I-NP	O
of	of	IN	B-PP	O
C.	C.	NNP	B-NP	O
diff	diff	NNP	I-NP	O
colitis	colitis	NN	I-NP	O
,	,	,	O	O
C.	C.	FW	B-NP	O
diff	diff	NN	I-NP	O
was	be	VBD	B-VP	O
the	the	DT	B-NP	O
most	most	RBS	I-NP	O
likely	likely	JJ	I-NP	O
infectious	infectious	JJ	I-NP	O
etiology	etiology	NN	I-NP	O
,	,	,	O	O
but	but	CC	O	O
others	other	NNS	B-NP	O
were	be	VBD	B-VP	O
possible	possible	JJ	B-ADJP	O
.	.	.	O	O

Ischemic	Ischemic	JJ	B-NP	O
colitis	colitis	NN	I-NP	O
was	be	VBD	B-VP	O
considered	consider	VBN	I-VP	O
secondary	secondary	JJ	B-ADJP	O
to	to	TO	B-PP	O
low	low	JJ	B-NP	O
forward	forward	JJ	I-NP	O
flow	flow	NN	I-NP	O
,	,	,	O	O
given	give	VBN	B-PP	O
patient	patient	NN	B-NP	O
's	's	POS	B-NP	O
cardiomyopathy	cardiomyopathy	NN	I-NP	O
and	and	CC	O	O
low	low	JJ	B-NP	O
ejection	ejection	NN	I-NP	O
fraction	fraction	NN	I-NP	O
of	of	IN	B-PP	O
20	20	CD	B-NP	O
%	%	NN	I-NP	O
to	to	TO	B-PP	O
35	35	CD	B-NP	O
%	%	NN	I-NP	O
and	and	CC	O	O
he	he	PRP	B-NP	O
also	also	RB	B-ADVP	O
got	get	VBD	B-VP	O
a	a	DT	B-NP	O
pattern	pattern	NN	I-NP	O
of	of	IN	B-PP	O
inflammatory	inflammatory	JJ	B-NP	O
colitis	colitis	NN	I-NP	O
or	or	CC	O	O
nonspecific	nonspecific	JJ	B-NP	O
colitis	colitis	NN	I-NP	O
.	.	.	O	O

Stool	Stool	NN	B-NP	O
samples	sample	NNS	I-NP	O
were	be	VBD	B-VP	O
sent	send	VBN	I-VP	O
for	for	IN	B-PP	O
a	a	DT	B-NP	O
C.	C.	NNP	I-NP	O
diff	diff	NN	I-NP	O
toxin	toxin	NN	I-NP	O
and	and	CC	I-NP	O
assay	assay	NN	I-NP	O
and	and	CC	O	O
all	all	DT	B-NP	O
were	be	VBD	B-VP	O
negative	negative	JJ	B-NP	O
x	x	NN	I-NP	O
at	at	IN	B-NP	O
least	least	JJS	I-NP	O
3	3	CD	I-NP	O
samples	sample	NNS	I-NP	O
.	.	.	O	O

Stool	Stool	NN	B-NP	B-cell_line
cultures	culture	NNS	I-NP	I-cell_line
were	be	VBD	B-VP	O
sent	send	VBN	I-VP	O
and	and	CC	O	O
did	do	VBD	B-VP	O
not	not	RB	I-VP	O
grow	grow	VB	I-VP	O
anything	anything	NN	B-NP	O
out	out	RB	B-ADVP	O
during	during	IN	B-PP	O
admission	admission	NN	B-NP	O
.	.	.	O	O

Empiric	Empiric	JJ	B-NP	O
treatment	treatment	NN	I-NP	O
was	be	VBD	B-VP	O
started	start	VBN	I-VP	O
with	with	IN	B-PP	O
p.o.	p.o.	FW	B-NP	O
vancomycin	vancomycin	NN	I-NP	O
.	.	.	O	O

Patient	Patient	NNP	B-NP	O
's	's	POS	B-NP	O
abdominal	abdominal	JJ	I-NP	O
pain	pain	NN	I-NP	O
continued	continue	VBD	B-VP	O
to	to	TO	I-VP	O
improve	improve	VB	I-VP	O
and	and	CC	O	O
completely	completely	RB	B-VP	O
resolved	resolve	VBN	I-VP	O
.	.	.	O	O

By	By	IN	B-PP	O
discharge	discharge	NN	B-NP	O
,	,	,	O	O
patient	patient	NN	B-NP	O
remained	remain	VBD	B-VP	O
afebrile	afebrile	JJ	B-NP	O
and	and	CC	I-NP	O
white	white	JJ	I-NP	O
blood	blood	NN	I-NP	O
cell	cell	NN	I-NP	O
count	count	NN	I-NP	O
decreased	decrease	VBD	B-VP	O
.	.	.	O	O

Advance	Advance	NN	B-NP	O
patient	patient	NN	I-NP	O
's	's	POS	B-NP	O
diet	diet	NN	I-NP	O
as	as	IN	B-SBAR	O
tolerated	tolerate	VBN	B-VP	O
and	and	CC	O	O
by	by	IN	B-PP	O
discharge	discharge	NN	B-NP	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
up	up	RB	B-ADVP	O
to	to	TO	B-PP	O
soft	soft	JJ	B-NP	O
solids	solid	NNS	I-NP	O
.	.	.	O	O

We	We	PRP	B-NP	O
added	add	VBD	B-VP	O
lactobacillus	lactobacillus	NN	B-NP	O
p.o.	p.o.	NN	I-NP	O
for	for	IN	B-PP	O
probiotics	probiotic	NNS	B-NP	O
and	and	CC	I-NP	O
patient	patient	NN	I-NP	O
also	also	RB	B-ADVP	O
had	have	VBD	B-VP	O
flex	flex	NN	B-NP	O
sig	sig	NN	I-NP	O
two	two	CD	B-NP	O
days	day	NNS	I-NP	O
before	before	IN	B-PP	O
discharge	discharge	NN	B-NP	O
,	,	,	O	O
showing	show	VBG	B-VP	O
resolving	resolve	VBG	B-NP	O
inflammation	inflammation	NN	I-NP	O
consistent	consistent	JJ	B-ADJP	O
with	with	IN	B-PP	O
colitis	colitis	NN	B-NP	O
of	of	IN	B-PP	O
inflammatory	inflammatory	JJ	B-NP	O
etiology	etiology	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
flex	flex	NN	I-NP	O
sig	sig	NN	I-NP	O
did	do	VBD	B-VP	O
not	not	RB	I-VP	O
change	change	VB	I-VP	O
his	his	PRP$	B-NP	O
management	management	NN	I-NP	O
.	.	.	O	O

We	We	PRP	B-NP	O
did	do	VBD	B-VP	O
discharge	discharge	VB	I-VP	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
on	on	IN	B-PP	O
a	a	DT	B-NP	O
2-week	2-week	JJ	I-NP	O
course	course	NN	I-NP	O
p.o.	p.o.	NN	I-NP	O
vancomycin	vancomycin	NN	I-NP	O
alone	alone	RB	B-ADVP	O
.	.	.	O	O

2	2	LS	B-LST	O
.	.	.	O	O

Coronary	Coronary	JJ	B-NP	O
artery	artery	NN	I-NP	O
disease	disease	NN	I-NP	O
.	.	.	O	O

Patient	Patient	NN	B-NP	O
had	have	VBD	B-VP	O
no	no	DT	B-NP	O
evidence	evidence	NN	I-NP	O
for	for	IN	B-PP	O
acute	acute	JJ	B-NP	O
coronary	coronary	JJ	I-NP	O
syndrome	syndrome	NN	I-NP	O
on	on	IN	B-PP	O
admission	admission	NN	B-NP	O
.	.	.	O	O

We	We	PRP	B-NP	O
continued	continue	VBD	B-VP	O
his	his	PRP$	B-NP	O
aspirin	aspirin	NN	I-NP	O
,	,	,	I-NP	O
Plavix	Plavix	NN	I-NP	O
,	,	,	I-NP	O
statin	statin	NN	I-NP	O
and	and	CC	I-NP	O
beta-blocker	beta-blocker	NN	I-NP	O
.	.	.	O	O

Patient	Patient	NN	B-NP	O
had	have	VBD	B-VP	O
no	no	DT	B-NP	O
ischemic	ischemic	JJ	I-NP	O
issues	issue	NNS	I-NP	O
or	or	CC	O	O
coronary	coronary	JJ	B-NP	O
artery	artery	NN	I-NP	O
disease	disease	NN	I-NP	O
issues	issue	NNS	I-NP	O
during	during	IN	B-PP	O
his	his	PRP$	B-NP	O
admission	admission	NN	I-NP	O
.	.	.	O	O

3	3	LS	B-LST	O
.	.	.	O	O

CHF	CHF	NN	B-NP	B-protein
.	.	.	O	O

Patient	Patient	NN	B-NP	O
has	have	VBZ	B-VP	O
previous	previous	JJ	B-NP	O
EF	EF	NN	I-NP	O
noted	note	VBD	B-VP	O
at	at	IN	B-PP	O
20	20	CD	B-NP	O
%	%	NN	I-NP	O
to	to	TO	B-PP	O
35	35	CD	B-NP	O
%	%	NN	I-NP	O
,	,	,	O	O
so	so	RB	O	O
a	a	DT	B-NP	O
gentle	gentle	JJ	I-NP	O
hydration	hydration	NN	I-NP	O
therapy	therapy	NN	I-NP	O
at	at	IN	B-PP	O
first	first	JJ	B-ADJP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
MICU	MICU	NN	I-NP	B-DNA
for	for	IN	B-PP	O
hypertension	hypertension	NN	B-NP	O
and	and	CC	O	O
then	then	RB	B-ADVP	O
as	as	IN	B-PP	O
patient	patient	NN	B-NP	O
's	's	POS	B-NP	O
blood	blood	NN	I-NP	O
pressure	pressure	NN	I-NP	O
increased	increase	VBD	B-VP	O
,	,	,	O	O
was	be	VBD	B-VP	O
able	able	JJ	B-ADJP	O
to	to	TO	B-VP	O
restart	restart	VB	I-VP	O
patient	patient	NN	B-NP	O
's	's	POS	B-NP	O
Lasix	Lasix	NNP	I-NP	O
dose	dose	NN	I-NP	O
in	in	IN	B-SBAR	O
order	order	NN	O	O
to	to	TO	B-VP	O
diurese	diurese	VB	I-VP	O
all	all	DT	B-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
extra	extra	JJ	I-NP	O
fluid	fluid	NN	I-NP	O
gained	gain	VBN	B-VP	O
during	during	IN	B-PP	O
the	the	DT	B-NP	O
rehydration	rehydration	NN	I-NP	O
therapy	therapy	NN	I-NP	O
,	,	,	O	O
was	be	VBD	B-VP	O
restarted	restart	VBN	I-VP	O
on	on	IN	B-PP	O
the	the	DT	B-NP	O
Lasix	Lasix	NNP	I-NP	O
40	40	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	RB	B-ADVP	O
daily	daily	RB	I-ADVP	O
,	,	,	O	O
his	his	PRP$	B-NP	O
daily	daily	JJ	I-NP	O
dose	dose	NN	I-NP	O
at	at	IN	B-PP	O
home	home	NN	B-NP	O
.	.	.	O	O

Also	Also	RB	B-NP	O
considered	consider	VBN	I-NP	O
restarting	restart	VBG	I-NP	O
lisinopril	lisinopril	NN	B-NP	O
,	,	,	O	O
but	but	CC	O	O
deferred	defer	VBD	B-VP	O
discharge	discharge	NN	B-NP	O
to	to	TO	B-PP	O
outpatient	outpatient	NN	B-NP	O
follow	follow	VB	B-VP	O
up	up	RP	B-PRT	O
with	with	IN	B-PP	O
primary	primary	JJ	B-NP	O
care	care	NN	I-NP	O
physician	physician	NN	I-NP	O
for	for	IN	B-PP	O
restart	restart	NN	B-NP	O
of	of	IN	B-PP	O
lisinopril	lisinopril	NN	B-NP	O
,	,	,	O	O
once	once	RB	B-ADVP	O
patient	patient	NN	B-NP	O
is	be	VBZ	B-VP	O
fully	fully	RB	B-ADJP	O
recovered	recover	VBN	I-ADJP	O
.	.	.	O	O

4	4	LS	B-LST	O
.	.	.	O	O

Chronic	Chronic	JJ	B-NP	O
kidney	kidney	NN	I-NP	O
disease	disease	NN	I-NP	O
.	.	.	O	O

Patient	Patient	NN	B-NP	O
had	have	VBD	B-VP	O
a	a	DT	B-NP	O
baseline	baseline	NN	I-NP	O
of	of	IN	B-PP	O
creatinine	creatinine	NN	B-NP	B-protein
1.2	1.2	CD	B-NP	I-protein
to	to	TO	I-NP	O
1.5	1.5	CD	I-NP	O
and	and	CC	O	O
he	he	PRP	B-NP	O
came	come	VBD	B-VP	O
into	into	IN	B-PP	O
the	the	DT	B-NP	O
hospital	hospital	NN	I-NP	O
with	with	IN	B-PP	O
a	a	DT	B-NP	O
creatinine	creatinine	NN	I-NP	O
of	of	IN	B-PP	O
1.0	1.0	CD	B-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
below	below	IN	B-PP	O
baseline	baseline	NN	B-NP	O
and	and	CC	O	O
remained	remain	VBD	B-VP	O
below	below	IN	B-PP	O
baseline	baseline	NN	B-NP	O
during	during	IN	B-PP	O
admission	admission	NN	B-NP	O
.	.	.	O	O

He	He	PRP	B-NP	O
did	do	VBD	B-VP	O
not	not	RB	I-VP	O
have	have	VB	I-VP	O
any	any	DT	B-NP	O
renal	renal	JJ	I-NP	O
issues	issue	NNS	I-NP	O
.	.	.	O	O

5	5	LS	B-LST	O
.	.	.	O	O

Hematology	Hematology	NN	B-NP	O
.	.	.	O	O

Patient	Patient	NN	B-NP	O
has	have	VBZ	B-VP	O
a	a	DT	B-NP	O
history	history	NN	I-NP	O
a	a	DT	B-NP	O
line-induced	line-induced	JJ	I-NP	O
DVT	DVT	NN	I-NP	O
,	,	,	O	O
has	have	VBZ	B-VP	O
been	be	VBN	I-VP	O
treated	treat	VBN	I-VP	O
with	with	IN	B-PP	O
Coumadin	Coumadin	NN	B-NP	O
,	,	,	O	O
with	with	IN	B-PP	O
no	no	DT	B-NP	O
definitive	definitive	JJ	I-NP	O
evidence	evidence	NN	I-NP	O
as	as	IN	B-PP	O
to	to	TO	B-PP	O
how	how	WRB	B-ADVP	O
along	along	IN	B-PP	O
patient	patient	NN	B-NP	O
should	should	MD	B-VP	O
be	be	VB	I-VP	O
treated	treat	VBN	I-VP	O
,	,	,	O	O
given	give	VBN	B-PP	O
that	that	IN	B-SBAR	O
the	the	DT	B-NP	O
DVT	DVT	NN	I-NP	B-cell_line
was	be	VBD	B-VP	I-cell_line
line	line	NN	B-NP	I-cell_line
induced	induce	VBN	B-VP	O
.	.	.	O	O

Coumadin	Coumadin	NN	B-NP	O
was	be	VBD	B-VP	O
therapeutic	therapeutic	JJ	B-ADJP	O
on	on	IN	B-PP	O
admission	admission	NN	B-NP	O
,	,	,	O	O
became	become	VBD	B-VP	O
supertherapeutic	supertherapeutic	JJ	B-ADJP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
MICU	MICU	NN	I-NP	B-DNA
.	.	.	O	O

Held	Held	JJ	B-NP	O
Coumadin	Coumadin	NN	I-NP	O
until	until	IN	B-SBAR	O
INR	INR	NN	B-NP	B-protein
fell	fall	VBD	B-VP	O
below	below	IN	B-PP	O
3	3	CD	B-NP	O
,	,	,	O	O
restarted	restart	VBD	B-VP	O
Coumadin	Coumadin	NN	B-NP	O
afterwards	afterwards	RB	B-ADVP	O
at	at	IN	B-PP	O
6	6	CD	B-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	RB	B-ADVP	O
daily	daily	RB	I-ADVP	O
,	,	,	O	O
patient	patient	NN	B-NP	O
's	's	POS	B-NP	O
normal	normal	JJ	I-NP	O
dose	dose	NN	I-NP	O
.	.	.	O	O

Patient	Patient	NN	B-NP	O
was	be	VBD	B-VP	O
therapeutic	therapeutic	JJ	B-ADJP	O
on	on	IN	B-PP	O
discharge	discharge	NN	B-NP	O
.	.	.	O	O

Will	Will	MD	B-VP	O
follow	follow	VB	I-VP	O
up	up	RP	B-PRT	O
with	with	IN	B-PP	O
primary	primary	JJ	B-NP	O
care	care	NN	I-NP	O
physician	physician	NN	I-NP	O
for	for	IN	B-PP	O
Coumadin	Coumadin	NN	B-NP	O
monitoring	monitoring	NN	I-NP	O
.	.	.	O	O

6	6	CD	B-NP	O
.	.	.	O	O

Nutrition	Nutrition	NN	B-NP	O
.	.	.	O	O

Patient	Patient	NN	B-NP	O
was	be	VBD	B-VP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
MICU	MICU	NN	I-NP	B-DNA
and	and	CC	O	O
was	be	VBD	B-VP	O
n.p.o.	n.p.o.	RB	I-VP	O
given	give	VBN	I-VP	O
abdominal	abdominal	JJ	B-NP	O
pain	pain	NN	I-NP	O
and	and	CC	I-NP	O
colitis	colitis	NN	I-NP	O
.	.	.	O	O

When	When	WRB	B-ADVP	O
transferred	transfer	VBN	B-VP	O
to	to	TO	B-PP	O
floor	floor	NN	B-NP	O
,	,	,	O	O
was	be	VBD	B-VP	O
started	start	VBN	I-VP	O
on	on	IN	B-PP	O
liquid	liquid	NN	B-NP	O
diet	diet	NN	I-NP	O
and	and	CC	O	O
advanced	advance	VBN	B-VP	O
to	to	TO	B-PP	O
soft	soft	JJ	B-NP	O
solid	solid	JJ	I-NP	O
diet	diet	NN	I-NP	O
.	.	.	O	O

By	By	IN	B-PP	O
discharge	discharge	NN	B-NP	O
,	,	,	O	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
did	do	VBD	B-VP	O
not	not	RB	I-VP	O
have	have	VB	I-VP	O
abdominal	abdominal	JJ	B-NP	O
pain	pain	NN	I-NP	O
and	and	CC	O	O
most	most	JJS	B-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
diarrhea	diarrhea	NN	I-NP	O
had	have	VBD	B-VP	O
resolved	resolve	VBN	I-VP	O
.	.	.	O	O

PROCEDURES	PROCEDURES	NNS	B-NP	O
PERFORMED	PERFORMED	VBD	B-VP	O
:	:	:	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
had	have	VBD	B-VP	O
a	a	DT	B-NP	O
flexible	flexible	JJ	I-NP	O
sigmoidoscopy	sigmoidoscopy	NN	I-NP	O
during	during	IN	B-PP	O
the	the	DT	B-NP	O
admission	admission	NN	I-NP	O
that	that	WDT	B-NP	O
showed	show	VBD	B-VP	O
colitis	colitis	NN	B-NP	O
consistent	consistent	JJ	B-ADJP	O
with	with	IN	B-PP	O
inflammatory	inflammatory	JJ	B-NP	O
etiology	etiology	NN	I-NP	O
.	.	.	O	O

DIAGNOSIS	DIAGNOSIS	NN	B-NP	O
:	:	:	O	O
Patient	Patient	NN	B-NP	O
had	have	VBD	B-VP	O
repeated	repeat	VBN	I-VP	O
negative	negative	JJ	B-NP	O
C.	C.	NNP	I-NP	O
diff	diff	NN	I-NP	O
toxin	toxin	NN	I-NP	O
assays	assay	NNS	I-NP	O
,	,	,	O	O
but	but	CC	O	O
colitis	colitis	NN	B-NP	O
was	be	VBD	B-VP	O
presumed	presume	VBN	I-VP	O
to	to	TO	I-VP	O
be	be	VB	I-VP	O
C.	C.	NNP	B-NP	O
diff	diff	NN	I-NP	O
and	and	CC	O	O
given	give	VBN	B-VP	O
history	history	NN	B-NP	O
,	,	,	O	O
could	could	MD	B-VP	O
have	have	VB	I-VP	O
been	be	VBN	I-VP	O
other	other	JJ	B-NP	O
infectious	infectious	JJ	I-NP	O
or	or	CC	I-NP	O
inflammatory	inflammatory	JJ	I-NP	O
etiologies	etiology	NNS	I-NP	O
.	.	.	O	O

Patient	Patient	NN	B-NP	O
continued	continue	VBD	B-VP	O
to	to	TO	I-VP	O
improve	improve	VB	I-VP	O
on	on	IN	B-PP	O
vancomycin	vancomycin	NN	B-NP	O
and	and	CC	O	O
thus	thus	RB	B-ADVP	O
was	be	VBD	B-VP	O
discharged	discharge	VBN	I-VP	O
with	with	IN	B-PP	O
presumed	presume	VBN	B-NP	O
C.	C.	NNP	I-NP	O
diff	diff	JJ	I-NP	O
colitis	colitis	NN	I-NP	O
diagnosis	diagnosis	NN	I-NP	O
.	.	.	O	O

DISCHARGE	DISCHARGE	NN	B-NP	O
MEDICATIONS	MEDICATIONS	NNS	I-NP	O
:	:	:	O	O
Included	Include	VBD	B-VP	O
aspirin	aspirin	NN	B-NP	O
81	81	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	RB	B-ADVP	O
daily	daily	RB	I-ADVP	O
,	,	,	O	O
Plavix	Plavix	NNP	B-NP	O
75	75	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	RB	B-ADVP	O
daily	daily	RB	I-ADVP	O
,	,	,	O	O
digoxin	digoxin	NN	B-NP	O
0.125	0.125	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	RB	B-ADVP	O
daily	daily	RB	I-ADVP	O
,	,	,	O	O
Nexium	Nexium	NN	B-NP	O
20	20	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	RB	B-ADVP	O
daily	daily	RB	I-ADVP	O
,	,	,	O	O
Flovent	Flovent	NNP	B-NP	O
110	110	CD	I-NP	O
mcg	mcg	NN	I-NP	O
inhale	inhale	NN	I-NP	O
b.i.d.	b.i.d.	NN	I-NP	O
,	,	,	O	O
Lasix	Lasix	NNP	B-NP	O
40	40	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	RB	B-ADVP	O
daily	daily	RB	I-ADVP	O
,	,	,	O	O
lactobacillus	lactobacillus	NN	B-NP	B-protein
2	2	CD	I-NP	I-protein
tabs	tab	NNS	I-NP	I-protein
p.o.	p.o.	FW	I-NP	O
t.i.d.	t.i.d.	NN	I-NP	O
,	,	,	O	O
metoprolol	metoprolol	NN	B-NP	O
25	25	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	FW	B-ADVP	O
b.i.d.	b.i.d.	FW	I-ADVP	O
,	,	,	O	O
simvastatin	simvastatin	NN	B-NP	O
80	80	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	NN	I-NP	O
at	at	IN	B-PP	O
bed	bed	NN	B-NP	O
time	time	NN	I-NP	O
,	,	,	O	O
Flomax	Flomax	NN	B-NP	O
0.4	0.4	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	FW	I-NP	O
every	every	DT	B-NP	O
evening	evening	NN	I-NP	O
,	,	,	O	O
vancomycin	vancomycin	NN	B-NP	O
250	250	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	FW	B-PP	O
every	every	DT	B-NP	O
6	6	CD	I-NP	O
hours	hour	NNS	I-NP	O
x8	x8	CD	B-NP	O
days	day	NNS	I-NP	O
at	at	IN	B-PP	O
discharge	discharge	NN	B-NP	O
and	and	CC	I-NP	O
Coumadin	Coumadin	NN	I-NP	O
5	5	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	FW	I-NP	O
every	every	DT	B-NP	O
evening	evening	NN	I-NP	O
.	.	.	O	O

Patient	Patient	NN	B-NP	O
had	have	VBD	B-VP	O
to	to	TO	I-VP	O
follow	follow	VB	I-VP	O
up	up	RP	B-PRT	O
with	with	IN	B-PP	O
primary	primary	JJ	B-NP	O
care	care	NN	I-NP	O
physician	physician	NN	I-NP	O
,	,	,	O	O
setup	setup	NN	B-NP	O
for	for	IN	B-PP	O
2	2	CD	B-NP	O
to	to	TO	I-NP	O
3	3	CD	I-NP	O
weeks	week	NNS	I-NP	O
after	after	IN	B-PP	O
discharge	discharge	NN	B-NP	O
.	.	.	O	O

eScription	eScription	NN	B-NP	O
document	document	NN	I-NP	O
:	:	:	O	O
3-2394135	3-2394135	CD	B-NP	O
HFFocus	HFFocus	NNP	I-NP	O
Dictated	Dictated	NNP	I-NP	O
By	By	NNP	I-NP	O
:	:	:	O	O
SOLLOCK	SOLLOCK	NNP	B-NP	O
,	,	,	O	O
SHELTON	SHELTON	NNP	B-NP	O
Attending	Attending	NNP	I-NP	O
:	:	:	O	O
VALLEJOS	VALLEJOS	NNP	B-NP	O
,	,	,	O	O
JAIME	JAIME	NNP	B-NP	O
TERRANCE	TERRANCE	NNP	I-NP	O
Dictation	Dictation	NNP	I-NP	O
ID	ID	NNP	I-NP	O
6308102	6308102	CD	I-NP	O
D	D	NNP	I-NP	O
:	:	:	O	O
10/27/06	10/27/06	CD	B-NP	O
T	T	NN	I-NP	O
:	:	:	O	O
4/24/06	4/24/06	CD	B-NP	O

